BioNTech Is Revising Plans for African Vaccine Factory Network
Source: BioNTech SE
This article is for subscribers only.
BioNTech SE is revising plans to build a manufacturing network of vaccine plants in three countries in Africa, just over a year after breaking ground on the first facility in Rwanda.
In a potential blow for Africa’s hopes of greater vaccine self-reliance, the German biotech company is currently not moving forward with a plan for a manufacturing facility in South Africa, according to people familiar with the project, who asked not to be identified discussing confidential information. In Senegal, BioNTech is now holding discussions about developing a smaller-scale manufacturing site or possibly an R&D center.